PMC:5848821 / 29164-29979 JSONTXT

Annnotations TAB JSON ListView MergeView

    TEST0

    {"project":"TEST0","denotations":[{"id":"28449028-137-143-6750","span":{"begin":473,"end":475},"obj":"[\"25819383\"]"},{"id":"28449028-169-175-6751","span":{"begin":647,"end":649},"obj":"[\"21093283\"]"},{"id":"28449028-159-165-6752","span":{"begin":811,"end":813},"obj":"[\"21093283\"]"}],"text":"Better OS and CSS of patients with MG may be explained by looking at diagnosis, resection status and type of surgery (MG+: 2.1% TCs, 17.4% incomplete resections and 10.6% EPPs in comparison with MG−: 15.2% TCs, 25.0% incomplete resections and 33.7% EPPs). There was an obvious difference in disease severity between the 2 study groups. In a study on 797 thymoma patients, a slight protective effect of MG on OS was observed that was not confirmed by multivariate analysis [12]. In patients with thymoma (Masaoka–Koga Stage I–IV), MG had an influence on histology and stage presentation, but only stage had a prognostic significance on OS and DFS [13]. Reasons for these observations may be associated with earlier diagnosis of TETs in MG patients (because of closer follow-up) or improvements in MG management [13]."}

    0_colil

    {"project":"0_colil","denotations":[{"id":"28449028-25819383-6750","span":{"begin":473,"end":475},"obj":"25819383"},{"id":"28449028-21093283-6751","span":{"begin":647,"end":649},"obj":"21093283"},{"id":"28449028-21093283-6752","span":{"begin":811,"end":813},"obj":"21093283"}],"text":"Better OS and CSS of patients with MG may be explained by looking at diagnosis, resection status and type of surgery (MG+: 2.1% TCs, 17.4% incomplete resections and 10.6% EPPs in comparison with MG−: 15.2% TCs, 25.0% incomplete resections and 33.7% EPPs). There was an obvious difference in disease severity between the 2 study groups. In a study on 797 thymoma patients, a slight protective effect of MG on OS was observed that was not confirmed by multivariate analysis [12]. In patients with thymoma (Masaoka–Koga Stage I–IV), MG had an influence on histology and stage presentation, but only stage had a prognostic significance on OS and DFS [13]. Reasons for these observations may be associated with earlier diagnosis of TETs in MG patients (because of closer follow-up) or improvements in MG management [13]."}

    2_test

    {"project":"2_test","denotations":[{"id":"28449028-25819383-28904957","span":{"begin":473,"end":475},"obj":"25819383"},{"id":"28449028-21093283-28904958","span":{"begin":647,"end":649},"obj":"21093283"},{"id":"28449028-21093283-28904959","span":{"begin":811,"end":813},"obj":"21093283"}],"text":"Better OS and CSS of patients with MG may be explained by looking at diagnosis, resection status and type of surgery (MG+: 2.1% TCs, 17.4% incomplete resections and 10.6% EPPs in comparison with MG−: 15.2% TCs, 25.0% incomplete resections and 33.7% EPPs). There was an obvious difference in disease severity between the 2 study groups. In a study on 797 thymoma patients, a slight protective effect of MG on OS was observed that was not confirmed by multivariate analysis [12]. In patients with thymoma (Masaoka–Koga Stage I–IV), MG had an influence on histology and stage presentation, but only stage had a prognostic significance on OS and DFS [13]. Reasons for these observations may be associated with earlier diagnosis of TETs in MG patients (because of closer follow-up) or improvements in MG management [13]."}

    MyTest

    {"project":"MyTest","denotations":[{"id":"28449028-25819383-28904957","span":{"begin":473,"end":475},"obj":"25819383"},{"id":"28449028-21093283-28904958","span":{"begin":647,"end":649},"obj":"21093283"},{"id":"28449028-21093283-28904959","span":{"begin":811,"end":813},"obj":"21093283"}],"namespaces":[{"prefix":"_base","uri":"https://www.uniprot.org/uniprot/testbase"},{"prefix":"UniProtKB","uri":"https://www.uniprot.org/uniprot/"},{"prefix":"uniprot","uri":"https://www.uniprot.org/uniprotkb/"}],"text":"Better OS and CSS of patients with MG may be explained by looking at diagnosis, resection status and type of surgery (MG+: 2.1% TCs, 17.4% incomplete resections and 10.6% EPPs in comparison with MG−: 15.2% TCs, 25.0% incomplete resections and 33.7% EPPs). There was an obvious difference in disease severity between the 2 study groups. In a study on 797 thymoma patients, a slight protective effect of MG on OS was observed that was not confirmed by multivariate analysis [12]. In patients with thymoma (Masaoka–Koga Stage I–IV), MG had an influence on histology and stage presentation, but only stage had a prognostic significance on OS and DFS [13]. Reasons for these observations may be associated with earlier diagnosis of TETs in MG patients (because of closer follow-up) or improvements in MG management [13]."}